Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus

2020 ◽  
Vol 34 (10) ◽  
pp. 2706-2711
Author(s):  
Akram Kooshki ◽  
Tahereh Tofighiyan ◽  
Neda Rastgoo ◽  
Mohammad Hassan Rakhshani ◽  
Mohammad Miri
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Diseases ◽  
Nigella Sativa ◽  
Nigella Sativa Oil

scholarly journals Age-related androgen deficiency and erectile dysfunction in men of the reproductive age presenting with type 2 diabetes mellitus

2013 ◽  
Vol 59 (1) ◽  
pp. 3-7
Author(s):  
R M Mamedgasanov ◽  
T V Mekhtiev
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Erectile Dysfunction ◽  
Cardiovascular Diseases ◽  
Androgen Deficiency ◽  
Congenital Diseases ◽  
Age Related

Aim of the study. To detect hypogonadism and elucidate its relationship with erectile dysfunction (ED) and the main risk factors of cardiovascular diseases (CVD) among the patients with type 2 diabetes mellitus (DM2). Materials and methods. This clinical epidemiological study included 261 men with DM2 at the age varying from 30 to 59 years. The following exclusion criteria were used: type 1 diabetes mellitus, primary hypogonadism, drug-induced and congenital diseases accompanied by hypogonadism, oncological and cardiovascular diseases. All the patients underwent routine clinical examination, questionnaire and instrumental studies, laboratory analysis including assays for sex hormones. Results. Hypogonadism was diagnosed based on the results of all above studies in 114 (43.7%) men presenting with type 2 diabetes mellitus whereas the AMS questionnaire revealed a 10% higher incidence of age-related hypogonadism (in 141 or 54% subjects). It means that the incidence of hypogonadism increases with age both among the patients with DM2 and in the general male population. For example, only 17.5% of the men at the age of 30-39 years suffered hypogonadism compared with thrice this frequency in the groups of 40-49 and 50-59 year-old subjects. The summarized international erectile function index (IEFI) in the patients with hypogonadism and DM2 was 14.2±0.5 compared with 19.0±0.9 in the group without hypogonadism (p<0.001). Erectile dysfunction was diagnosed in 42 (28.6%) of the 147 patients with DM2 in the absence of hypogonadism whereas all the patients with hypogonadism suffered ED. The groups of the patients presenting with DM2 and hypogonadism and with DM2 without hypogonadism were not significantly different in terms of the number of smokers and hypokinetic subjects (roughly 70%). A similar tendency was documented in the occurrence of such parameters as waist circumference and serum triglycerides levels whereas the total and LDLP cholesterol levels, arterial pressure and body mass index were significantly higher in the patients with hypogonadism. Conclusion. Almost each second man with type 2 diabetes mellitus suffers hypogonadism and the number of such patients increases with age. The presence of DM2 increases the risk of development of ED. Also, the probability of ED and its severity increase under effect of androgen deficiency. The combination of DM2 and hypogonadism promotes manifestation of the main risk factors of cardiovascular diseases.

A study of hemorrhological parameters as risk factors for cardiovascular diseases in Nigerian type 2 diabetes mellitus patients

2013 ◽  
Vol 10 (2) ◽  
pp. 72 ◽  
Author(s):  
Olatunde Odusan ◽  
O Olayemi ◽  
HusseanT Raimi ◽  
JacobO Adenuga ◽  
OlurantiB Familoni
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Diseases

Cardiovascular diseases and risk factors knowledge and awareness in people with type 2 diabetes mellitus: a global evaluation

2020 ◽  
Vol 165 ◽  
pp. 108194
Author(s):  
Pouya Saeedi ◽  
Suvi Karuranga ◽  
Lucy Hammond ◽  
Abha Kaundal ◽  
Belma Malanda ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Diseases ◽  
Global Evaluation

Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients

Endocrine ◽  
2019 ◽  
Vol 65 (2) ◽  
pp. 286-294 ◽  
Author(s):  
Hebatallah Ahmed Mohamed Moustafa ◽  
Lamia Mohamed El Wakeel ◽  
Mohamed Reda Halawa ◽  
Nagwa Ali Sabri ◽  
Alshaymaa Zaki El-Bahy ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Biochemical Parameters ◽  
Nigella Sativa ◽  
Newly Diagnosed ◽  
Nigella Sativa Oil
Sign in / Sign up

Export Citation Format

Share Document